Suicide stats fuel debate over SSRI drugs

The unintended consequences of managing SSRI drugs can be severe, according to a new federally-funded study of suicidal behavior among children. In 2003, the feds warned that the widely used antidepressants might increase the risk of suicide among the under-19 crowd. Not surprisingly, kid-sized prescriptions for Prozac and its ilk dropped.

But then the unforeseen happened. Suicides in that age group actually escalated by 14 percent from 2003 to 2004. That's a dramatic change in just one year--the most dramatic since the government started keeping those stats in 1979. There's no proof that a fall-off in antidepressant use caused the increase in suicides, but the study authors say few other explanations present themselves. And statistics show that, among population subgroups where antidepressant use is highest, suicides are lowest.

SSRI critics have other ideas, namely the increased use of antipsychotics among children. No doubt the debate will continue.

- check out the report from the Washington Post

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

The new Community trial will first test Amgen's Otezla, Takeda's Takhzyro and UCB's zilucoplan in hospitalized patients.

Indivior faces a new lawsuit from RB, its former parent company, over a scheme to market opioid addiction therapy Suboxone Film.

A new FDA effort brings cancer drug labels to life in videotaped panels with experts, debuting its first episode on Seagen's MBC med Tukysa.